Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 | Achieve Life Sciences Inc (ACHV) | XNAS | US | 2022-12-31 | 2 days ago | USD | 4.30 | 0.00 | 0.00% | 0.32 | 7.35% | Ungraded | 0.00 | 0.00% |
| 12 | Acacia Communications Inc (ACIA) | 2019-12-31 | 2 years ago | USD | 0.00 | 16.34 | 0.00% | 8.18 | 0.00% | NCAV (Net-Net) | 8.18 | 0.00% | ||
| 13 | AC Immune SA (ACIU) | XNAS | CH | 2022-12-31 | 2 days ago | CHF | 0.00 | 0.00 | 0.00% | 1.33 | 0.00% | Ungraded | 0.00 | 0.00% |
| 14 | Acorda Therapeutics Inc (ACOR) | XNAS | US | 2022-12-31 | 2 days ago | USD | 14.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 15 | Aclaris Therapeutics Inc (ACRS) | XNAS | US | 2022-12-31 | 2 days ago | USD | 6.85 | 0.00 | 0.00% | 2.62 | 38.21% | Ungraded | 0.00 | 0.00% |
| 16 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 2 days ago | USD | 0.58 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 17 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2022-12-31 | 2 days ago | USD | 0.78 | 0.00 | 0.00% | 0.04 | 4.72% | Ungraded | 0.00 | 0.00% |
| 18 | Adial Pharmaceuticals Inc (ADIL) | XNAS | US | 2022-12-31 | 2 days ago | USD | 2.78 | 0.00 | 0.00% | 2.17 | 77.99% | Ungraded | 0.00 | 0.00% |
| 19 | ADMA Biologics Inc (ADMA) | XNAS | US | 2022-12-31 | 2 days ago | USD | 3.58 | 0.00 | 0.00% | 0.33 | 9.31% | Ungraded | 0.00 | 0.00% |
| 20 | Adamis Pharmaceuticals Corp (ADMP) | XNAS | US | 2022-12-31 | 2 weeks ago | USD | 0.78 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |